Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:SR-1277 CAS:1446715-47-4 Package:25mg/RMB 10600
|
|
| 9H-Purin-6-amine, 2-(4-morpholinyl)-N-[(7-nitro-1H-benzimidazol-2-yl)methyl]-9-(3-thienyl)- Basic information |
| 9H-Purin-6-amine, 2-(4-morpholinyl)-N-[(7-nitro-1H-benzimidazol-2-yl)methyl]-9-(3-thienyl)- Chemical Properties |
Boiling point | 893.2±75.0 °C(Predicted) | density | 1.73±0.1 g/cm3(Predicted) | pka | 7.29±0.30(Predicted) |
| 9H-Purin-6-amine, 2-(4-morpholinyl)-N-[(7-nitro-1H-benzimidazol-2-yl)methyl]-9-(3-thienyl)- Usage And Synthesis |
Description | ML177 is a potent, selective and ATP competitive CK1δ/ε inhibitor. | Uses | SR-1277 is a potent, selective and ATP competitive CK1δ/ε inhibitor, with IC50s of 49 nM and 260 nM, respectively. SR-1277 also inhibits FLT3, CDK4/cyclin D1, CDK6/cyclin D3 and CDK9/cyclin K, with IC50s of 305 nM, 1340 nM, 311 nM and 109 nM, respectively. SR-1277 can be used for the research of cancer[1]. | in vivo | SR-1277 (1 mg/kg; i.v.) exhibits Cmax (1.2 μM), Cl (2.8 ml/min/kg), AUC(1.26 μM h), T1/2 (1.42 h) and brain penetration (24%) in mice[1]. | IC 50 | CKIδ: 49 nM (IC50) | References | [1] Bibian M, et, al. Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties. Bioorg Med Chem Lett. 2013 Aug 1;23(15):4374-80. DOI:10.1016/j.bmcl.2013.05.075 |
| 9H-Purin-6-amine, 2-(4-morpholinyl)-N-[(7-nitro-1H-benzimidazol-2-yl)methyl]-9-(3-thienyl)- Preparation Products And Raw materials |
|